BWX Technologies (NYSE: BWXT) says it has entered into a definitive agreement to sell its medical business to Nordic Capital. The transaction is valued at up to $800 million, according to the company. As part of the deal, BWXT will retain a minority ownership interest in the new company that Nordic Capital will form. The announcements describe Nordic Capital as a healthcare investor with experience in the radiopharmaceutical industry and its value chain.
Both outlets report the same core terms: BWXT’s medical business is being transferred under a definitive agreement, the consideration is structured as a deal value that can reach as high as $800 million, and BWXT remains invested through a minority stake in the resulting entity. The companies’ statements do not indicate additional deal details in the provided excerpts, such as closing timing, regulatory approvals, or specific operational changes following the transaction.
